 |
Melphalan |
|---|---|
| Trade Name | Alkeran For Injection |
| Orphan Indication | Metastatic Melanoma |
| USA Market Approval | USA |
| USA Designation Date | 1992-03-03 00:00:00 |
| Sponsor | Glaxo Wellcome Research and Development;5 Moore Drive, PO Box 13398;Research Triangle Park, North Carolina, 27709 |
